• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Study the Key Players in Rheumatoid Arthritis Research & Development With This New Clinical Trial Monitoring Brief Today

Posted on: Wednesday, 5 September 2007, 09:03 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c67413) has announced the addition of Trial TRAX - Rheumatoid Arthritis - Clinical Trial Monitoring Brief to their offering.

The main body of the brief presents key data points from competitor clinical trials in a matrix format, enabling decision-makers the ability to quickly recall and analyze information on competitor studies. The brief's reference-guide format is designed to provide decision makers with easy access to key intelligence on competitive clinical development programs. Primary data points include:

Study Drug

Mechanism of Action

Company-Sponsor

Phase of Development

Number of Patients

Study Design

Primary Endpoints

Study Start Date

Clients utilize the Trial TRAX briefing reports to:

Monitor clinical development programs of competitors

Quickly evaluate depth and breadth of competitive landscape

Easy-to-use reference guide for analyzing competitor clinical trials

Identify potential patient recruitment challenges

Benchmark competitor clinical trial designs

Products mentioned in the report:

Enbrel

Ocrelizumab

Content Outline:

Section 1: Executive Summary Rheumatoid Arthritis Disease Overview: Background, Epidemiology, and Severity Clinical Endpoints Utilized in Rheumatoid Arthritis Trials Overview of Clinical Landscape Key Players in Rheumatoid Arthritis R&D Section 2: Ongoing Clinical Trial in Rheumatoid Arthritis Phase 1 Clinical Trial Details Phase 2 Clinical Trial Details Phase 3 Clinical Trial Details

Section 3: Appendix Disclaimer Report Licensing

The Trial TRAX Clinical Intelligence Monitoring series provides detailed compilations and analysis of ongoing clinical studies within a specific therapeutic area or indication. Additionally, the Trial TRAX briefs contain synthesized background information on the profiled-disease; typically includes top-line information on:

Epidemiology

Patient Segmentation

Clinical endpoints

The Trial TRAX brief also contains analysis of the clinical landscape with assessments including:

% utilization of key clinical endpoints

Number of ongoing trials (by phase of development)

Key companies sponsoring clinical trials

Companies Mentioned:

Amgen

Biogen

Eli Lilly

Genentech

Pfizer

Wyeth

For more information visit http://www.researchandmarkets.com/reports/c67413

Source: Business Wire

More News in this Category